What Researchers Did
Researchers evaluated the effectiveness of therapeutic hyperventilation with maintenance of isocapnia (IH) in eliminating carbon monoxide (CO) in 13 healthy, chronically-smoking volunteers, comparing it to hyperventilation with pure oxygen (NIH).
What They Found
Among 13 volunteers (8 women, 5 men), the initial carboxyhemoglobin (COHb) level was 5.0±1.5%. Researchers measured COHb levels and selected gasometric, cardiac, and respiratory parameters at 0, 10, and 20 minutes during both isocapnic hyperventilation and non-isocapnic hyperventilation tests.
What This Means for Canadian Patients
If proven effective, therapeutic hyperventilation with isocapnia could offer an additional or alternative treatment option for Canadian patients suffering from carbon monoxide intoxication. This method might be particularly useful in situations where hyperbaric oxygen therapy is not readily available or feasible.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants or institutions.
Study Limitations
A limitation of this study is its small sample size of 13 healthy, chronically-smoking volunteers, and the short observation period of 20 minutes.